HT
CPRX

HAP Trading’s Catalyst Pharmaceutical CPRX Stock Holding History

HAP Trading’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,800
Closed -$34K – 1268
2022
Q4 		$34K Buy
+12,800
New +$197K ﹤0.01% 832
2022
Q2 		– Sell
-10,700
Closed -$12K – 1998
2022
Q1 		$12K Sell
10,700
-6,300
-37% -$44.5K ﹤0.01% 1721
2021
Q4 		$11K Buy
17,000
+2,100
+14% +$13.8K ﹤0.01% 2019
2021
Q3 		$4K Buy
14,900
+300
+2% +$1.64K ﹤0.01% 2199
2021
Q2 		$3K Sell
14,600
-2,300
-14% -$11.9K ﹤0.01% 2213
2021
Q1 		$5K Buy
16,900
+1,300
+8% +$5.17K ﹤0.01% 1748
2020
Q4 		$3K Buy
15,600
+700
+5% +$2.35K ﹤0.01% 2081
2020
Q3 		$3K Buy
+14,900
New +$58.3K ﹤0.01% 1481
2017
Q3 		– Sell
-315,000
Closed -$399K – 914
2017
Q2 		$399K Hold
315,000
– – 0.02% 398
2017
Q1 		$165K Buy
+315,000
New +$401K 0.01% 504

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return